top of page

HaemaLogiX appoints haematologist Angela Dispenzieri, M.D. to its Scientific Advisory Board

Laptop On Tray_edited_edited_edited.jpg

30 January 2024

HaemaLogiX Ltd, a clinical stage biotech, is pleased to announce the appointment of Professor of Medicine and of Laboratory Medicine and Pathology Angela Dispenzieri, M.D. to its Scientific Advisory Board (SAB).


Dr. Dispenzieri is currently Professor of Medicine and of Laboratory Medicine at the Mayo Clinic in Rochester, Minnesota. She has joint appointments in the Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, and the Department of Molecular Medicine.


Dr. Dispenzieri conducts research in plasma cell disorders, including multiple myeloma, amyloidosis, POEMS syndrome and other rare plasma cell disorders. She has been an author or co-author on over 600 journal articles, book chapters, and abstracts in the field of plasma cell disorders, including multiple myeloma, immunoglobulin light chain amyloidosis, POEMS syndrome, Castleman Disease, and mass spectrometry techniques.


HaemaLogiX’s Chief Scientific Officer, Dr. Rosanne Dunn, said: “HaemaLogiX is delighted to welcome Professor Angela Dispenzieri to our Scientific Advisory Board as an expert in the treatment of patients with AL amyloidosis, multiple myeloma and POEMS syndrome. We look forward to working closely with her on the clinical development of our immunotherapies for these diseases.”


Dr. Dispenzieri earned her B.S. in biology at the Massachusetts Institute of Technology and her M.D. at Albert Einstein College of Medicine. She subsequently completed a residency and a fellowship in Hematology and Oncology at Mayo Clinic. Dr. Dispenzieri joined the staff of Mayo Clinic in 1998 and served as Chair of Hematology Research from 2014 to 2022. She currently chairs the Mayo Clinic Amyloid Interest Group.


Dr. Dispenzieri is recognised with the distinction of a named professorship, the Serene M. and Frances C. Durling Professorship.


She has had leadership roles in international amyloid and myeloma societies including being a past treasurer and past president of the International Society of Amyloidosis and past treasurer for the International Myeloma Society. She is Vice President for the International Kidney and Monoclonal Gammopathy Society.

bottom of page